Company intelligence / Profile preview

PreveCeutical Medical Inc.

Vancouver, British Columbia, Canadapreveceutical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

PreveCeutical is developing multiple programs including cannabinoid sol-gel delivery systems, non-addictive analgesic peptides, BSV peptide program for cancer, and dual gene therapy for diabetes and obesity. The company is currently in pre-clinical evaluation stages.

Therapeutic areas: OncologyEndocrinologyNeurology
Modalities: PeptidesSol-Gel Delivery SystemCannabinoidsGene Therapy
Industry: Biotech

Drug pipeline

4 assets

Cannabinoid Sol-Gel

Preclinical

3 more assets in the full pipeline.

Request access →

Partnerships

University of QueenslandUniQuest

Beyond the preview

Go deeper on PreveCeutical Medical Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PreveCeutical Medical Inc..

Explore the full profile